Skip to main content
Earnings Labs
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT)

NASDAQ·Healthcare·Biotechnology

$32.07

+3.75%

Mkt Cap $5.42B

Analyst Ratings

Buy

6

Hold

0

Sell

0

Price Target (23 analysts)

$51.75

Range $45.00 – $55.00

Implied Upside

+61.4%

Consensus $51.75 vs current $32.07